Amanote Research
Register
Sign In
NRSN2 Promotes Breast Cancer Metastasis by Activating PI3K/AKT/mTOR and NF‑κB Signaling Pathways
Oncology Letters
- Greece
doi 10.3892/ol.2019.11152
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
November 28, 2019
Authors
Fei Ren
Wei Zhang
Shuai Lu
Hong Ren
Yantong Guo
Publisher
Spandidos Publications
Related search
HSPC159 Promotes Proliferation and Metastasis via Inducing EMT and Activating PI3K/Akt Pathway in Breast Cancer
Cancer Science
Cancer Research
Medicine
Oncology
Estrogen Promotes Progression of Hormone-Dependent Breast Cancer Through CCL2-CCR2 Axis by Upregulation of Twist via PI3K/AKT/NF-κB Signaling
Scientific Reports
Multidisciplinary
CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
Cancer Management and Research
Oncology
RIP2 Promotes Glioma Cell Growth by Regulating TRAF3 and Activating the NF‑κB and P38 Signaling Pathways
Oncology Reports
Medicine
Cancer Research
Oncology
Oxymatrine Induces Nasopharyngeal Cancer Cell Death Through Inhibition of PI3K/AKT and NF‑κB Pathways
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
ZNF692 Promotes Colon Adenocarcinoma Cell Growth and Metastasis by Activating the PI3K/AKT Pathway
International Journal of Oncology
Cancer Research
Oncology
FOXC1 Promotes Melanoma by Activating MST1R/PI3K/AKT
Oncotarget
Oncology
DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-κB Pathway in Colorectal Cancer
International Journal of Cancer
Cancer Research
Oncology
Gambogic Acid Prevents Angiotensin II‑induced Abdominal Aortic Aneurysm Through Inflammatory and Oxidative Stress Dependent Targeting the PI3K/Akt/mTOR and NF‑κB Signaling Pathways
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine